CME Funding Faces Uncertain Future

High anxiety concerning the future of pharmaceutical funding of continuing medical education permeated the Alliance for Continuing Medical Education annual conference, held January 28–31 in San Francisco. In numerous sessions, attendees and speakers discussed how the increasingly strict regulatory environment and negative public, media, and government perception of CME is threatening collaboration between CME providers and pharmaceutical company grantors.